A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

NCT06846866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: BMS-986419
DRUG: BMS-986419 Matching Placebo
DRUG: Moxifloxacin
DRUG: Moxifloxacin Matching Placebo

Sponsor

Bristol-Myers Squibb